Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (NY:BUD)

61.59 +0.03 (+0.05%)
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Unpacking Q4 Earnings: Molson Coors (NYSE:TAP) In The Context Of Other Beverages, Alcohol, and Tobacco Stocks
Looking back on beverages, alcohol, and tobacco stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Molson Coors (NYSE:TAP) and its peers. 
Via StockStory
Topics Cannabis
Exposures Cannabis
Is Altria Group a Buy, Sell, or Hold in 2025?
This slow and steady Dividend King has amassed market-beating returns over the past year. 
Via The Motley Fool
Topics World Trade
Exposures Tariff
AskSlim Market Week - March, Feb. 28
An analysis and commentary on the financial markets. 
Via Talk Markets
Topics Bonds Commodities Stocks / Equities
Winners And Losers Of Q4: Philip Morris (NYSE:PM) Vs The Rest Of The Beverages, Alcohol, and Tobacco Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Philip Morris (NYSE:PM) and the... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Top 3 Risk Off Stocks That May Plunge In Q1
Via Benzinga
Is the Market Bullish or Bearish on Anheuser-Busch InBev?
Via Benzinga
2 Reasons to Like BUD (and 1 Not So Much)
Over the past six months, Anheuser-Busch’s stock price fell to $61.52. Shareholders have lost 6.1% of their capital, disappointing when considering the S&P 500 was flat. This might have investors... 
Via StockStory
Topics Stocks
Exposures US Equities
Q4 Earnings Outperformers: Monster (NASDAQ:MNST) And The Rest Of The Beverages, Alcohol, and Tobacco Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at beverages, alcohol, and tobacco stocks,... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Beverages, Alcohol, and Tobacco Stocks Q4 Recap: Benchmarking Tilray (NASDAQ:TLRY)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Tilray (NASDAQ:TLRY) and the best and worst... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For February 26, 2025
Via Benzinga
3 Stocks Warren Buffett Just Bought
Via The Motley Fool
A Look Back at Beverages, Alcohol, and Tobacco Stocks’ Q4 Earnings: Celsius (NASDAQ:CELH) Vs The Rest Of The Pack
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Celsius (NASDAQ:CELH) and its peers. 
Via StockStory
Topics Cannabis
Exposures Cannabis
2 Consumer Stocks with Exciting Potential and 1 to Brush Off
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. Unfortunately, the sector hasn’t provided much protection lately as it pulled back by 10.4% over... 
Via StockStory
Topics Stocks
Exposures US Equities
How Is The Market Feeling About Anheuser-Busch InBev?
Via Benzinga
A Look Back at Beverages, Alcohol, and Tobacco Stocks’ Q4 Earnings: Brown-Forman (NYSE:BF.B) Vs The Rest Of The Pack
Let’s dig into the relative performance of Brown-Forman (NYSE:BF.B) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season. 
Via StockStory
Topics Cannabis
Exposures Cannabis
Q4 Earnings Highs And Lows: Zevia (NYSE:ZVIA) Vs The Rest Of The Beverages, Alcohol, and Tobacco Stocks
Let’s dig into the relative performance of Zevia (NYSE:ZVIA) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season. 
Via StockStory
Topics Cannabis
Exposures Cannabis
1 Mooning Stock with Solid Fundamentals and 2 to Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
Reflecting On Beverages, Alcohol, and Tobacco Stocks’ Q4 Earnings: Vita Coco (NASDAQ:COCO)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at beverages, alcohol, and tobacco stocks,... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Where Will Altria Stock Be in 5 Years?
The domestic tobacco leader is still growing at a slow-but-steady rate. 
Via The Motley Fool
Options Corner: Why Anheuser-Busch Could Ironically Be The Beer Of The 'Silent Majority'
Although Anheuser-Busch previously sparked conservative uproar, shifting political winds now smile on BUD stock. 
Via Benzinga
Beverages, Alcohol, and Tobacco Stocks Q4 In Review: MGP Ingredients (NASDAQ:MGPI) Vs Peers
Let’s dig into the relative performance of MGP Ingredients (NASDAQ:MGPI) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season. 
Via StockStory
Topics Cannabis
Exposures Cannabis
Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
These large-cap stocks were top performers last week. Heico, Xpeng, Li Auto, Lineage, Erie Indemnity, Lloyds, Unum, FICO, Masimo, Smith & Nephew, AB InBev, and Nutanix all saw significant gains. 
Via Benzinga
Anheuser-Busch Stock Rallies—Is the King of Beers Back?
BUD stock is moving higher after posting record full-year revenue on lower volume; solid fundamentals suggest the stock may have room to run higher 
Via MarketBeat
Anheuser-Busch (NYSE:BUD) Reports Q4 Results
Beer powerhouse Anheuser-Busch InBev (NYSE:BUD) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 2.5% year on year to $14.84 billion. Its GAAP profit of $0.61 per share... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Are Anheuser-Busch (BUD) Shares Soaring Today
Shares of beer powerhouse Anheuser-Busch InBev (NYSE:BUD) jumped 9.1% in the morning session after the company reported decent fourth-quarter 2024 results, with EPS slightly exceeding analysts'... 
Via StockStory
Topics Initial Public Offering
Exposures Securities Market
Anheuser-Busch InBev/NV (BUD) Q4 2024 Earnings Call Transcript
BUD earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Budweiser Parent Anheuser-Busch Says 'Beer Is A Passion Point For Consumers' On Strong Q4 Performance
Anheuser-Busch InBev (NYSE: BUD) reported a 3.4% YoY sales growth for Q4 FY24, reaching $14.84 billion, surpassing analyst expectations. Despite a slight decline in beer volumes, the company saw a 4.3%... 
Via Benzinga
Celsius Pops on Acquisition and Earnings
Celsius Holdings' stock surged after a strong earnings report and a major acquisition, signaling a potential resurgence for the energy drink maker. 
Via MarketBeat
Warren Buffett Unfazed By Trump's Tariff Threats: Oracle Of Omaha Bets On Mexico, Beer
Warren Buffett bought a beer stock in the fourth quarter, which could be unique since he doesn't drink. The move also comes as the stock faces pressure from President Donald Trump. 
Via Benzinga
Topics Government
Exposures Political
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.